Except for lower levels of 11β-OH-3α,5α-THA in patients, the levels of remaining 11β-hydroxy-androstanes were unaltered, which may indicate unaltered functioning of CYP11B1 in MS patients. The gene discussed is CYP11B1; the disease is myeloid sarcoma.